Oxford Gene Technology (OGT), The Molecular Genetics Company, has expanded its SureSeq myPanel NGS Custom Cancer Panel content - now covering 120 fully optimised cancer related genes
Oxford Gene Technology has expanded its SureSeq myPanel NGS Custom Cancer Panel content. The expansion comes in response to increasing use of NGS as a tool for research into an increasing number of cancer types allowing researchers to obtain reliable data for difficult-to-sequence genes and mutations.
Oxford Gene Technology (OGT) has annouced the latest version (4.5.3) of its CytoSure Interpret software
Oxford Gene Technology (OGT), a provider of innovative genetics research and biomarker solutions to advanced molecular medicine, has released a free-to-download demo version of its Genefficiency NGS Variant Analysis Report software
Oxford Gene Technology has produced a new, free-to-download application note on combined array comparative genomic hybridisation and single nucleotide polymorphism arrays
Microarray analysis tool aims to provide researchers with 'biologically meaningful' results
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
